Former Mayo Clinic Director Sues Over AI Safety Concerns
Traci Tamiko Eto alleges the health system retaliated after she flagged compliance lapses in its artificial intelligence research programs.

A former research operations director at Mayo Clinic has filed a federal lawsuit alleging the health system retaliated against her after she repeatedly raised concerns about artificial intelligence safety protocols and patient privacy protections.
Traci Tamiko Eto, who joined Mayo Clinic in December 2023, claims she spent 18 months documenting what she describes as serious compliance failures in the organization's AI research programs before being demoted and ultimately terminated.
The allegations
According to the complaint filed July 6 in U.S. District Court for the District of Minnesota, Eto was hired as director of research operations with responsibility for aligning Mayo's practices with federal AI governance standards. She oversaw a team of 36 employees.
During her tenure, Eto identified multiple instances where she believed Mayo violated federal research rules. The lawsuit details three specific concerns: a study of Mayo's digital assistant tool that allegedly bypassed institutional review board approval, patient data that was mishandled during de-identification processes, and a cardiac surgical procedure that received unauthorized approval without proper institutional review.
Eto claims she escalated these issues to Mayo leadership, but the organization chose to prioritize speed and competitive positioning over regulatory compliance.
The alleged retaliation
The lawsuit states that in July 2025, Eto was removed from her supervisory role. She subsequently requested medical leave under the Family and Medical Leave Act, which Mayo initially denied before approving it after she retained legal counsel.
While on leave, Eto received notice that her position was being eliminated as part of a reduction in force. According to the complaint, her role was the only one affected by this reduction. She applied for 15 internal positions at Mayo, received one interview, and was formally terminated on December 1, 2025.
The lawsuit further alleges that Mayo minimized Eto's contributions on a patent application for an AI tool she helped design and maintained an internal system marking her as ineligible for rehire.
Mayo's response
Mayo Clinic defended its AI practices in a statement to MedCity News, which first reported the lawsuit. The health system said it remains "committed to the responsible development and deployment of AI, with privacy, security, transparency and compliance embedded throughout [its] processes."
While declining to comment on active litigation, Mayo stated that its "research and clinical innovation are conducted in accordance with applicable laws and regulations."
Why it matters
This case arrives as healthcare organizations race to deploy AI tools while navigating an evolving regulatory landscape. The allegations highlight the tension between innovation velocity and compliance rigor — a balance that becomes especially critical when patient data and safety are involved. For health systems investing heavily in AI capabilities, the lawsuit underscores the importance of robust governance frameworks and the potential legal and reputational risks of inadequate oversight.
Legal claims
Eto is seeking a jury trial and damages under three federal statutes: the retaliation provision of the False Claims Act, the Americans with Disabilities Act, and the Family and Medical Leave Act. She is requesting back pay, front pay, lost benefits, and both compensatory and punitive damages.
The details of this lawsuit were first reported by MedCity News.
This is an original analysis by the Omega editorial team. Source reporting: AI Watch.
Want systems like this working for your business?
Book a Call
